LeadIQ logo
Learn more at LeadIQ.com

Insights

Rapid Growth & Acquisitions Galecto has demonstrated significant expansion potential through recent acquisitions like Damora Therapeutics and substantial private funding of 285 million dollars, indicating a strong growth trajectory and openness to strategic partnerships.

Innovative Research Focus With a deep expertise in fibrosis, inflammation, and cancer biology, Galecto develops novel small molecule therapeutics and actively shares data at major conferences like the ASH Annual Meeting, creating opportunities for collaboration on cutting-edge treatments.

Financial Capacity Although currently revenue is modest (1-10 million USD), the company’s funded status at 64 million USD provides ample resources to invest in research, clinical trials, and potential technology integrations.

Senior Leadership Expansion Recent strategic hires including CMO and COO suggest Galecto is investing in medical and operational expertise, opening doors for partnerships in clinical development and operational support services.

Technology & Data Transparency Leveraging cloud technologies and analytics platforms like Google Cloud and Google Analytics indicates a modern approach to research and data management, providing opportunities for technology providers or data integration collaborations.

Galecto, Inc. Tech Stack

Galecto, Inc. uses 8 technology products and services including Google Cloud, Underscore.js, Yoast SEO, and more. Explore Galecto, Inc.'s tech stack below.

  • Google Cloud
    Infrastructure As A Service
  • Underscore.js
    Javascript Libraries
  • Yoast SEO
    Search Engines
  • X-XSS-Protection
    Security
  • MediaElement.js
    Video Players
  • Google Analytics
    Web Analytics
  • Acquia Cloud Site Factory
    Web Hosting
  • Nginx
    Web Servers

Media & News

Galecto, Inc.'s Email Address Formats

Galecto, Inc. uses at least 1 format(s):
Galecto, Inc. Email FormatsExamplePercentage
First.Last@galecto.comJohn.Doe@galecto.com
46%
FL@galecto.comJD@galecto.com
34%
FLast@galecto.comJDoe@galecto.com
18%
FirstLast@galecto.comJohnDoe@galecto.com
2%

Frequently Asked Questions

Where is Galecto, Inc.'s headquarters located?

Minus sign iconPlus sign iconGalecto, Inc.'s main headquarters is located at 3 Ole Maaloes Vej Copenhagen, Hovedstaden dk-2200 Denmark. The company has employees across 3 continents, including EuropeAsiaNorth America.

What is Galecto, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact Galecto, Inc.'s main corporate office by phone at
+45-26-37-3****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Galecto, Inc.'s stock symbol?

Minus sign iconPlus sign iconGalecto, Inc. is a publicly traded company; the company's stock symbol is GLTO.

What is Galecto, Inc.'s official website and social media links?

Minus sign iconPlus sign iconGalecto, Inc.'s official website is galecto.com and has social profiles on LinkedInCrunchbase.

What is Galecto, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconGalecto, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Galecto, Inc. have currently?

Minus sign iconPlus sign iconAs of April 2026, Galecto, Inc. has approximately 13 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Coo: A. H. P.Chief Medical Officer: B. H.Chief Business Officer: S. O.. Explore Galecto, Inc.'s employee directory with LeadIQ.

What industry does Galecto, Inc. belong to?

Minus sign iconPlus sign iconGalecto, Inc. operates in the Biotechnology Research industry.

What technology does Galecto, Inc. use?

Minus sign iconPlus sign iconGalecto, Inc.'s tech stack includes Google CloudUnderscore.jsYoast SEOX-XSS-ProtectionMediaElement.jsGoogle AnalyticsAcquia Cloud Site FactoryNginx.

What is Galecto, Inc.'s email format?

Minus sign iconPlus sign iconGalecto, Inc.'s email format typically follows the pattern of First.Last@galecto.com. Find more Galecto, Inc. email formats with LeadIQ.

How much funding has Galecto, Inc. raised to date?

Minus sign iconPlus sign icon As of April 2026, Galecto, Inc. has raised $64M in funding. The last funding round occurred on Sep 25, 2020 for $64M.

When was Galecto, Inc. founded?

Minus sign iconPlus sign iconGalecto, Inc. was founded in 2011.

Galecto, Inc.

Biotechnology ResearchHovedstaden, Denmark11-50 Employees

Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer.

Galecto was founded by leading fibrosis-focused scientists and biotech executives and is built on more than 10 years of research into galectin and fibrosis modulators. Our team has developed a deep understanding of the galectin family of proteins and the LOXL2 enzyme, and how both influence multiple biological pathways of these complex, often devastating, diseases.

Galecto is funded by Novo Holdings, OrbiMed, Ysios, HBM Healthcare Investments, Sunstone Capital, M Ventures, Bristol-Myers Squibb, Maverick Ventures, Seventure and SEED Capital.

Section iconCompany Overview

Headquarters
3 Ole Maaloes Vej Copenhagen, Hovedstaden dk-2200 Denmark
Phone number
+45-26-37-3****
Website
galecto.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
GLTO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $64M

    Galecto, Inc. has raised a total of $64M of funding over 4 rounds. Their latest funding round was raised on Sep 25, 2020 in the amount of $64M.

  • $1M$10M

    Galecto, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $64M

    Galecto, Inc. has raised a total of $64M of funding over 4 rounds. Their latest funding round was raised on Sep 25, 2020 in the amount of $64M.

  • $1M$10M

    Galecto, Inc.'s revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    A. H. P.
    Coo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. H.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. O.
    Chief Business Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. S.
    Co-Founder
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. G.
    Senior Director Of Clinical Project Management
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    S. U. C.
    Corporate Controller
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. G.
    Senior Director Of Clinical Project Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. V. P.
    Manager, It And Compliance
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. S.
    Consultant Physician
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. W.
    General Counsel, Corporate Secretary
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.